Spots Global Cancer Trial Database for female reproductive cancer

Every month we try and update this database with for female reproductive cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma	NCT00390234	Fallopian Tube ... Female Reproduc... Ovarian Carcino... Ovarian Sarcoma Recurrent Ovari... Recurrent Uteri... Stage III Ovari... Stage III Uteri... Stage IV Ovaria... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo...	ziv-aflibercept	18 Years -	National Cancer Institute (NCI)
Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery	NCT01867606	Female Reproduc...	serum-derived b... placebo laboratory biom... quality-of-life... questionnaire a...	18 Years -	Mayo Clinic
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer	NCT02096783	Anxiety Disorde... Cervical Cancer Endometrial Can... Female Reproduc... Gestational Tro... Ovarian Epithel... Ovarian Germ Ce... Sexual Dysfunct... Uterine Sarcoma Vaginal Cancer Vulvar Cancer	informational i... counseling inte... questionnaire a...	18 Years -	University of Wisconsin, Madison
A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers	NCT05544929	Carcinoma, Non-... Cutaneous Melan... Carcinoma, Rena... Carcinoma, Ovar... Nasopharyngeal ... Carcinoma, Thym... Anal Cancer Mesothelioma Esophagogastric... High Microsatel... Squamous Cell C... Triple Negative...	KFA115 pembrolizumab	18 Years -	Novartis
Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery	NCT01867606	Female Reproduc...	serum-derived b... placebo laboratory biom... quality-of-life... questionnaire a...	18 Years -	Mayo Clinic
Feeding Schedules After Surgery in Patients With Gynecologic Cancer	NCT00742677	Female Reproduc...	nutritional sup...	- 75 Years	National Cancer Institute (NCI)
A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers	NCT05544929	Carcinoma, Non-... Cutaneous Melan... Carcinoma, Rena... Carcinoma, Ovar... Nasopharyngeal ... Carcinoma, Thym... Anal Cancer Mesothelioma Esophagogastric... High Microsatel... Squamous Cell C... Triple Negative...	KFA115 pembrolizumab	18 Years -	Novartis
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer	NCT02096783	Anxiety Disorde... Cervical Cancer Endometrial Can... Female Reproduc... Gestational Tro... Ovarian Epithel... Ovarian Germ Ce... Sexual Dysfunct... Uterine Sarcoma Vaginal Cancer Vulvar Cancer	informational i... counseling inte... questionnaire a...	18 Years -	University of Wisconsin, Madison
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer	NCT00182767	Fallopian Tube ... Female Reproduc... Recurrent Breas... Recurrent Ovari... Stage III Ovari... Stage IV Breast... Stage IV Ovaria...	ixabepilone pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer	NCT00182767	Fallopian Tube ... Female Reproduc... Recurrent Breas... Recurrent Ovari... Stage III Ovari... Stage IV Breast... Stage IV Ovaria...	ixabepilone pegylated lipos...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: